Low levels of resistance have been detected against one of the newest antibiotics, ceftazidime-avibactam, which has been used in the NHS since 2017, the UK Health Security Agency (UKHSA) has warned.

Health officials have warned that bacteria have already become resistant to one of the newest antibiotics on the NHS ...

Infectious diseases specialist warns of antibiotic misuse leading to drug resistance, urges strict regulation for newer ...

Ceftazidime and avibactam are two anti-infective drugs that can prove difficult to analyze in serum. Determining them can ...

Ceftazidime-avibactam is a β-lactam/β-lactamase inhibitor combination restricted for the treatment of multidrug-resistant infections of Pseudomonas aeruginosa non-susceptible to ceftazidime and ...